• 1. Disulfide- and terminal alkyne-functionalized magnetic silica particles for enrichment of azido glycopeptides?
  Sheng Wang,Wenxian Xie,Xiu Zhang,Xia Zou,Yan Zhang Chem. Commun., 2012,48, 5907-5909
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 4. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 5. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726

Chloropalladium(1+); Dicyclohexyl-[2-(2,4,6-triisopropylphenyl)phenyl]phosphane; 2-phenylethanamine: A Comprehensive Overview

The compound with the CAS number 1028206-56-5 is a fascinating subject of study in the field of organometallic chemistry and pharmaceutical research. This article delves into the detailed characteristics, applications, and recent advancements involving Chloropalladium(1+); Dicyclohexyl-[2-(2,4,6-triisopropylphenyl)phenyl]phosphane; 2-phenylethanamine, highlighting its significance in modern chemical biology and medicinal chemistry.

At its core, Chloropalladium(1+); Dicyclohexyl-[2-(2,4,6-triisopropylphenyl)phenyl]phosphane; 2-phenylethanamine is a complex organometallic compound featuring a palladium(1+) center coordinated with a dicyclohexylphosphine ligand and an amine substituent. The presence of bulky isopropyl groups in the phenyl ring enhances steric hindrance, which is a crucial factor in its reactivity and stability. This unique structural arrangement makes it an intriguing candidate for various catalytic applications.

In recent years, significant research has been focused on the catalytic properties of this compound. Its ability to facilitate cross-coupling reactions, particularly Suzuki-Miyaura couplings, has been extensively studied. The dicyclohexylphosphine ligand not only stabilizes the palladium center but also influences the electronic properties of the complex, making it highly effective in promoting various organic transformations. These findings have opened new avenues in the synthesis of complex organic molecules, which are essential for pharmaceutical development.

The amine group in Chloropalladium(1+); Dicyclohexyl-[2-(2,4,6-triisopropylphenyl)phenyl]phosphane; 2-phenylethanamine adds another layer of functionality to the compound. This group can participate in hydrogen bonding interactions, making it a valuable component in supramolecular chemistry and materials science. Additionally, the amine moiety can be further functionalized to create more complex derivatives with tailored properties.

Recent studies have also explored the biological activity of this compound. The palladium center is known to interact with various biological targets, making it a potential candidate for therapeutic applications. For instance, palladium complexes have shown promise in anticancer therapies due to their ability to induce DNA damage and inhibit tumor growth. The specific steric and electronic environment provided by Chloropalladium(1+); Dicyclohexyl-[2-(2,4,6-triisopropylphenyl)phenyl]phosphane; 2-phenylethanamine could enhance its efficacy in such applications.

The synthesis of this compound involves multiple steps, each requiring precise control over reaction conditions to ensure high yield and purity. The use of high-purity starting materials and controlled reaction environments is crucial to achieving the desired product. Advanced synthetic techniques such as transition-metal catalysis and ligand design play a pivotal role in optimizing these processes.

In conclusion, Chloropalladium(1+); Dicyclohexyl-[2-(2,4,6-triisopropylphenyl)phenyl]phosphane; 2-phenylethanamine represents a significant advancement in organometallic chemistry and pharmaceutical research. Its unique structural features and versatile reactivity make it a valuable tool for both synthetic chemists and medicinal chemists. As research continues to uncover new applications for this compound, its importance in advancing chemical biology and drug development is undeniable.

• 564483-18-7(dicyclohexyl[2',4',6'-tris(propan-2-yl)-[1,1'-biphenyl]-2-yl]phosphane)
• 1661884-13-4(Dicyclohexyl(2',4',6'-triisopropyl-[1,1':3',1"-terphenyl]-2-yl)phosphane, 97%)
• 1142811-12-8(ditert-butyl-[2-(2,4,6-triisopropylphenyl)phenyl]phosphane;palladium(2+);2-phenylethanamine;chloride)
• 251320-85-1(Phosphine,dicyclohexyl[2'-(1-methylethyl)[1,1'-biphenyl]-2-yl]-)
• 862780-38-9(PHOSPHINE, DICYCLOPENTYL[2',4',6'-TRIS(1-METHYLETHYL)[1,1'-BIPHENYL]-2-YL]-)
• 854045-94-6(2-Dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl gold(I) chloride)
• 637030-69-4(Phosphine, dicyclohexyl(2'-ethyl[1,1'-biphenyl]-2-yl)-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)